Important information from BCBSM regarding MAT revenue opportunity
During this public health emergency, we are aware that as a result of addressing the coronavirus, physician offices are faced with challenges that interrupt their normal routines. We recognize that social distancing may be impacting patient visits and placing financial strain on practices. For this reason, we want to remind PO leadership of the opportunity available to your providers who have been trained to offer medication assisted treatment (MAT) to patients suffering from opioid use disorder. These patients remain in need of services and may present an opportunity to generate revenue while also earning additional PGIP incentives.
Patients suffering from opioid use disorder often need regular office visits, which may now be done via telemedicine due to the public health emergency declaration (see DEA link below and attached). PCMH designated providers are eligible to earn practice transformation rewards of up to $20,000, and the PO would receive up to $5,000 per practice who earn the reward. Additionally, eligible PCMH physicians and specialists can also earn up to 5% value-based reimbursement.
For providers who may be interested in offering MAT, the Michigan Opioid Collaborative can assist with developing or enhancing your current process. Please direct any questions to email@example.com. An option for virtual meetings for patients in need of that service is also listed below.
BCBSM incentive information can be found on the Medication Assisted Treatment page of the PGIP collaboration site. Any BCBSM-related questions can be directed to David Bye at firstname.lastname@example.org.
DEA update and resources: https://www.deadiversion.usdoj.gov/coronavirus.html
Michigan Opioid Collaborative: https://medicine.umich.edu/dept/psychiatry/programs/michigan-opioid-collaborative-moc
Virtual meetings: https://unityrecovery.org/digital-recovery-meetings